Abstract
Musculoskeletal manifestations such as myalgias, arthralgias, an intermittent non-erosive mild polyarthritis affecting mainly small joints, are common in patients with primary Sjögren’s syndrome. Myositis may also occur but much less frequently. The most important features of these manifestations are described in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pertovaara M, Pukkala E, Laippala P, et al. A longitudinal cohort study of Finnish patients with primary Sjögren’s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis. 2001;60:467–72.
Ioannidis J, Vassiliou V, Moutsopoulos H. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren’s syndrome. Arthritis Rheum. 2002;46:741–7.
Theander E, Manthorpe R, Jacobsson L. Mortality and causes of death in primary Sjögren’s syndrome: a prospective cohort study. Arthritis Rheum. 2004;50:1262–9.
Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, et al. Epidemiology of primary Sjögren’s syndrome in north-west Greece, 1982–2003. Rheumatology (Oxford). 2006;45:187–91.
Ramos-Casals M, Solans R, Rosas J, et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87:210–9.
Haga HJ, Peen E. A study of the arthritis pattern in primary Sjögren’s syndrome. Clin Exp Rheumatol. 2007;25:88–91.
Kruize AA, Hené RJ, Van Der Heide A, et al. Long-term followup of patients with Sjögren’s syndrome. Arthritis Rheum. 1996;39:297–303.
Haga HJ, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjögren’s syndrome. Scand J Rheumatol. 1999;28:227–32.
Ramos-Casals M, Cervera R, Font J, et al. Young onset of primary Sjögren’s syndrome: clinical and immunological characteristics. Lupus. 1998;7:202–6.
García-Carrasco M, Cervera R, Rosas J, et al. Primary Sjögren’s syndrome in the elderly: clinical and immunological characteristics. Lupus. 1999;8:20–3.
Barrs DM, McDonald TJ, Duffy J. Sjögren’s syndrome involving the larynx: report of a case. J Laryngol Otol. 1979;93:933–6.
Sève P, Poupart M, Bui-Xuan C, et al. Cricoarytenoid arthritis in Sjögren’s syndrome. Rheumatol Int. 2005;25:301–2.
García-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270–80.
Kamali S, Polat NG, Kasapoglu E, et al. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren’s syndrome, and Wegener’s granulomatosis. Clin Rheumatol. 2005;24:673–6.
Atzeni F, Sarzi-Puttini P, Lama N, et al. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis. Arthritis Res Ther. 2008;10:1–6.
Papiris SA, Tsonis IA, Moutsopoulos HM. Sjögren’s syndrome. Semin Respir Crit Care Med. 2007;28:459–71.
Rehman HU. Sjögren’s syndrome. Yonsei Med J. 2003;44:947–54.
Castro-Poltronieri A, Alarcón-Segovia D. Articular manifestations of primary Sjögren’s syndrome. J Rheumatol. 1983;10:485–8.
Rantapaa-Dahlqvist SR, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptides and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741–9.
Gottenberg JE, Mignot S, Nicaise-Rolland P, et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome. Ann Rheum Dis. 2005;64:114–7.
Goëb V, Salle V, Duhaut P, et al. Clinical significance of autoantibodies recognizing Sjögren’s syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren’s syndrome. Clin Exp Immunol. 2007;148:281–7.
Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore). 1993;72:113–24.
Spilberg I, Siltzbach LE, McEwen C. The arthritis of sarcoidosis. Arthritis Rheum. 1969;12:126–37.
Petri MA. In: Koopman WJ, editor. Arthritis and allied conditions – a textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams & Wilkin; 2001. p. 1455–79.
Martinez-Lavin M, Vaughan JH, Tan EM. Autoantibodies and the spectrum of Sjögren’s syndrome. Ann Intern Med. 1979;91:185–90.
Vitali C, Tavoni A, Neri R, et al. Fibromyalgia features in patients with primary Sjögren’s syndrome. Evidence of a relationship with psychological depression. Scand J Rheumatol. 1989;18:21–7.
Tishler M, Barak Y, Paran D, et al. Sleep disturbances, fibromyalgia and primary Sjögren’s syndrome. Clin Exp Rheumatol. 1997;15:71–4.
Lindvall B, Bengtsson A, Ernerudh J, et al. Subclinical myositis is common in primary Sjögren’s syndrome and is not related to muscle pain. J Rheumatol. 2002;29:717–25.
Alexander EL. Neuromuscular complications of primary Sjögren’s syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, editors. Sjögren’s syndrome. Clinical and immunological aspects. Berlin: Springer; 1987. p. 61–82.
Chad D, Good P, Adelman L, et al. Inclusion body myositis associated with Sjögren’s syndrome. Arch Neurol. 1982;39:186–8.
Gutmann L, Govindan S, Riggs JE, et al. Inclusion body myositis and Sjögren’s syndrome. Arch Neurol. 1985;42:1021–2.
Khraishi MM, Jay V, Keystone EC. Inclusion body myositis in association with vitamin B12 deficiency and Sjögren’s syndrome. J Rheumatol. 1992;19:306–9.
Vrethem M, Lindvall B, Holmgren H, et al. Neuropathy and myopathy in primary Sjögren’s syndrome: neurophysiological, immunological and muscle biopsy results. Acta Neurol Scand. 1990;82:126–31.
Kraus A, Cifuentes M, Villa AR, et al. Myositis in primary Sjögren’s syndrome. Report of 3 cases. J Rheumatol. 1994;21:649–53.
Molina R, Provost TT, Arnett FC, et al. Primary Sjögren’s syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med. 1986;80:23–31.
Ringel SP, Forstot JZ, Tan EM, et al. Sjögren’s syndrome and polymyositis or dermatomyositis. Arch Neurol. 1982;39:157–63.
Layzer RB. Inflammatory and immune disorders. In: Layzer RB, editor. Neuromuscular manifestations of systemic disease. Philadelphia: Davis; 1985. p. 227–8.
Leroy JP, Drosos AA, Yiannopoulos DI, et al. Intravenous pulse cyclophosphamide therapy in myositis and Sjögren’s syndrome. Arthritis Rheum. 1990;33:1579–81.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Pons-Estel, G.J., Pons-Estel, B.A., Alarcón, G.S. (2011). Musculoskeletal Involvement. In: Ramos-Casals, M., Stone, J., Moutsopoulos, H. (eds) Sjögren’s Syndrome. Springer, London. https://doi.org/10.1007/978-0-85729-947-5_10
Download citation
DOI: https://doi.org/10.1007/978-0-85729-947-5_10
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-946-8
Online ISBN: 978-0-85729-947-5
eBook Packages: MedicineMedicine (R0)